Last reviewed · How we verify
BPI-1178
At a glance
| Generic name | BPI-1178 |
|---|---|
| Also known as | BPI-1178 capsule |
| Sponsor | Beta Pharma (Suzhou) Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Study of BPI-1178 in Patients With Advanced Solid Tumor and HR+/HER2- Breast Cancer (PHASE1, PHASE2)
- A Study With BPI-1178 and Osimertinib in Advanced Non-small Cell Lung Cancer Patients With EGFR Mutations (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |